8GPY
Crystal structure of Omicron BA.4/5 RBD in complex with a neutralizing antibody scFv
8GPY の概要
| エントリーDOI | 10.2210/pdb8gpy/pdb |
| 分子名称 | Spike protein S1, scFv (3 entities in total) |
| 機能のキーワード | omicron, crystal strcture, neutralizing antibody, scfv, viral protein |
| 由来する生物種 | Severe acute respiratory syndrome coronavirus 2 詳細 |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 94481.44 |
| 構造登録者 | |
| 主引用文献 | Guo, Y.,Zhang, G.,Yang, Q.,Xie, X.,Lu, Y.,Cheng, X.,Wang, H.,Liang, J.,Tang, J.,Gao, Y.,Shang, H.,Dai, J.,Shi, Y.,Zhou, J.,Zhou, J.,Guo, H.,Yang, H.,Qi, J.,Liu, L.,Ma, S.,Zhang, B.,Huo, Q.,Xie, Y.,Wu, J.,Dong, F.,Zhang, S.,Lou, Z.,Gao, Y.,Song, Z.,Wang, W.,Sun, Z.,Yang, X.,Xiong, D.,Liu, F.,Chen, X.,Zhu, P.,Wang, X.,Cheng, T.,Rao, Z. Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection. Nat Commun, 14:3537-3537, 2023 Cited by PubMed Abstract: The SARS-CoV-2 Omicron variant evades most currently approved neutralizing antibodies (nAbs) and caused drastic decrease of plasma neutralizing activity elicited by vaccination or prior infection, urging the need for the development of pan-variant antivirals. Breakthrough infection induces a hybrid immunological response with potentially broad, potent and durable protection against variants, therefore, convalescent plasma from breakthrough infection may provide a broadened repertoire for identifying elite nAbs. We performed single-cell RNA sequencing (scRNA-seq) and BCR sequencing (scBCR-seq) of B cells from BA.1 breakthrough-infected patients who received 2 or 3 previous doses of inactivated vaccine. Elite nAbs, mainly derived from the IGHV2-5 and IGHV3-66/53 germlines, showed potent neutralizing activity across Wuhan-Hu-1, Delta, Omicron sublineages BA.1 and BA.2 at picomolar NT values. Cryo-EM analysis revealed diverse modes of spike recognition and guides the design of cocktail therapy. A single injection of paired antibodies cocktail provided potent protection in the K18-hACE2 transgenic female mouse model of SARS-CoV-2 infection. PubMed: 37322000DOI: 10.1038/s41467-023-39267-x 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.51 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






